Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Atanasoff KE"'
Autor:
Atanasoff KE; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Ophir SI; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Parsons AJ; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Paredes Casado J; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Lurain NS; Department of Immunology-Microbiology, Rush University, Chicago, IL, USA., Bowlin TL; Microbiotix, Inc., Worcester, MA, 01605, USA., Opperman TJ; Microbiotix, Inc., Worcester, MA, 01605, USA., Tortorella D; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. Electronic address: domenico.tortorella@mssm.edu.
Publikováno v:
Antiviral research [Antiviral Res] 2024 Nov 27; Vol. 233, pp. 106044. Date of Electronic Publication: 2024 Nov 27.
Autor:
Atanasoff KE; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Parsons AJ; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Ophir SI; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Lurain N; Department of Immunology-Microbiology, Rush University, Chicago, Illinois, USA., Kraus T; Center for Therapeutic Antibody Development, Drug Discovery Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Moran T; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Center for Therapeutic Antibody Development, Drug Discovery Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Duty JA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Center for Therapeutic Antibody Development, Drug Discovery Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Tortorella D; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Publikováno v:
Journal of virology [J Virol] 2024 Jul 23; Vol. 98 (7), pp. e0021324. Date of Electronic Publication: 2024 Jun 04.
An in vitro experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibody.
Autor:
Atanasoff KE; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Brambilla L; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Adelsberg DC; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Kowdle S; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Stevens CS; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Slamanig S; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands., Hung C-T; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Fu Y; Sorrento Therapeutics, Inc., San Diego, California, USA., Lim R; Sorrento Therapeutics, Inc., San Diego, California, USA., Tran L; Sorrento Therapeutics, Inc., San Diego, California, USA., Allen R; Sorrento Therapeutics, Inc., San Diego, California, USA., Sun W; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Duty JA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Center for Therapeutic Antibody Development, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Bajic G; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Lee B; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Tortorella D; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Publikováno v:
MBio [mBio] 2024 Jan 16; Vol. 15 (1), pp. e0247723. Date of Electronic Publication: 2023 Dec 06.
Autor:
Parsons AJ; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Stein KR; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Atanasoff KE; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Ophir SI; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Casado JP; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Tortorella D; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Publikováno v:
The Journal of general virology [J Gen Virol] 2023 Sep; Vol. 104 (9).
Autor:
Atanasoff KE, Brambilla L, Adelsberg DC, Kowdle S, Stevens CS, Hung CT, Fu Y, Lim R, Tran L, Allen R, Andrew Duty J, Bajic G, Lee B, Tortorella D
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Apr 21. Date of Electronic Publication: 2023 Apr 21.
Autor:
Parsons AJ; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Ophir SI; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Gardner TJ; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Paredes JC; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Stein KR; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Kwasny SM; Microbiotix, Inc., Worcester, MA, 01605, USA., Cardinale SC; Microbiotix, Inc., Worcester, MA, 01605, USA., Torhan M; Microbiotix, Inc., Worcester, MA, 01605, USA., Prichard MN; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, 35233, USA., James SH; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, 35233, USA., Atanasoff KE; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., G-Dayanandan N; Microbiotix, Inc., Worcester, MA, 01605, USA., Bowlin TL; Microbiotix, Inc., Worcester, MA, 01605, USA., Opperman TJ; Microbiotix, Inc., Worcester, MA, 01605, USA. Electronic address: topperman@microbiotix.com., Tortorella D; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. Electronic address: domenico.tortorella@mssm.edu.
Publikováno v:
Antiviral research [Antiviral Res] 2023 Jan; Vol. 209, pp. 105474. Date of Electronic Publication: 2022 Nov 26.